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Abstract  
 
Background：Kangfuxin Liquid is extracted from America periplaneta, which is effective for treating gastrointestinal 
ulcers and repairing gastrointestinal mucosal tissue. The purpose of this study is to explore the effect of Kangfuxin 
Liquid on improving intestinal barrier dysfunction in elderly patients using mechanical ventilation and effectively 
restraining the concentration of D-lactate. 
Materials and Methods： Elderly patients with mechanical ventilation were selected, and divided into “control” and 
“treatment” groups by using a random number table. Patients in both groups were given conventional treatment. 
Patients in “treatment group” additionally received Kangfuxin Liquid. At baseline and at 3, 7days following treatment, 
recordings for the concentration of D-lactate, intra-abdominal pressure (IAP) and bowel sounds were conducted. The 
duration of mechanical ventilation, the time of stay in ICU and the mortality rate during 28 days were recorded.  
Results: At baseline, there were no significant differences in the terms of the concentrations of D-lactate, IAP and 
bowel sounds in the two groups (P>0.05). At 3 and 7days following treatment, the concentration of D-lactate, IAP and 
bowel sounds in the “treatment group” were better than those in the “control group”. The differences were statistically 
significant (P<0.05). The duration of mechanical ventilation and the time of stay in intensive care unit (ICU) in the 
treatment group were less than those in the control group (P<0.05). 
Conclusion: Kangfuxin Liquid can restrain the concentration of D-lactate, improves intestinal mucosal permeability, 
enhances the intestinal barrier, and improves the condition in elderly patients with mechanical ventilation. 
 
Keywords: Kangfuxin Liquid, The elderly, Intestinal barrier, D- lactate. 
 
Abbreviations: IAP, intra-abdominal pressure; ICU, intensive care unit; SIRS, systemic inflammatory response 
syndrome; MODS, multiple organ dysfunction syndrome; IgA, immunoglobulin A ; IgG, immunoglobulin G.  
 
Introduction 
 
During recent years, elderly patients with mechanical ventilation are gradually rising as a result of population 
demographics. The reserve of intestinal barrier function in the elderly patient declines, intestinal vascular shrink under 
the condition of mechanical ventilation, accompanied by ischemia and hypoxia of mucosal tissue. Consequently 
Article History 
Received: Sept. 23, 2016 
Revised Received: Dec. 28, 2017 
Accepted: Dec. 28, 2017 
Published Online: Feb. 23, 2018. 
 
112 
 
intestinal barrier dysfunction and worse yet- failure often occurs (Pan et al., 2016). When elderly patients have 
intestinal barrier dysfunction, it can be argued that this condition had been aggravated or alternatively that the 
prognosis was poor (Geboes et al., 2002). Therefore, it has practical significance to protect elderly patients who have 
intestinal barrier function with mechanical ventilation in the early stage. 
At present, the topic of elderly patients in critical stages with intestinal barrier dysfunction has been receiving 
more attention and likewise its prevention. Many traditional medicines for treating intestinal barrier dysfunction have 
achieved satisfactory results (Qiu et al., 2011; Fang et al., 2006). Kangfuxin Liquid is extracted from America 
periplaneta, which belongs to the insect medicines with effectiveness on gastrointestinal ulcer and repairs 
gastrointestinal mucosal tissue (Wang et al., 2013; Zhang et al., 2012). Kangfuxin Liquid is used to improve the 
intestinal barrier dysfunction in elderly patients, and explore the effect on restraining the concentration of D-lactate. 
 
Materials and Methods 
 
Trial design: This study used a prospective randomized controlled trial and the sample size was first established and 
evaluated. The subject patients were assigned into “treatment” and “control” groups using a random number table with 
thirty-one patients comprising each group. The detection and record of evaluation index was performed by two 
independent investigators. Both investigators were unaware of the treatment allocation.  
 
Study population: During the period January 2010 to December 2012, a total of 62 elderly patients with mechanical 
ventilation in ICU were selected from our hospitals, 35 male, 27 female, ranging in age from 61 to 75 years. Their 
primary diseases were severe pneumonia, pulmonary embolism, chest trauma, cerebro-vascular disease, brain injury, 
poisoning, and other illnesses.  
 
Ethics: This research protocol was approved by our hospital’s committee in accordance with the ethical standards set 
out in the 1964 Declaration of Helsinki and its later amendments. Before commencing this study all patients or their 
families were informed, consent given for treatment, and an agreement was signed. . 
 
Inclusion criteria: The patients with mechanical ventilation were older than 60 years of age; Their APACHE II score 
was greater than or equal to 12 points; and their records indicated they never had peptic ulcers or any other 
gastrointestinal disease.  
 
Exclusion criteria: Patients not chosen were those who had the following issues: Patients who had used anti 
cholinergic or gastrointestinal motility medicines within the previous week, those suffering from primary disease in 
their digestive system, others with severe intra- abdominal infections, those infected with human immunodeficiency 
virus, and those with Parkinson's disease, hyperthyroidism and epilepsy. 
 
Intervention: All patients were provided comprehensive treatment, including the treatment of their initial disease, 
blood transfusion, oxygen, analgesic sedation, maintenance of water electrolyte balance and any other considerations. 
There were no statistically differences between these two sample groups. “Treatment” patients additionally received 
Kangfuxin Liquid (Hunan Kelun Pharmaceutical Co., Ltd. Chian), Kangfuxin Liquid via a naso-gastric tube, 10 ml 
each time, 3 times each day, for 7 days.  
 
Evaluation index: At baseline and at 3 and 7 day intervals following treatment, all patients were respectively extracted 
venous blood for testing the concentration of D-lactate. At the same time, intra-abdominal pressure (IAP) and bowel 
sounds were recorded. Monitoring of intra-abdominal pressure was conducted by bladder manometry (Wang et al., 
2015). The duration of mechanical ventilation, the time of stay in ICU and the mortality rate during 28 days were 
recorded. Any adverse drug reactions in all enrolled patients during this trial were recorded. 
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Statistical analysis: The analysis was determined applying SPSS17.0 software (SPSS software Inc., Chicago, IL, 
USA). Continuous data was expressed as mean ± standard deviation; the differences between groups were tested with 
the Student t-test. Percentage and non-normally distributed data were compared for statistical significance using Chi 
square-test
 
or the Mann-Whitney U-test. The significance level was established at p <0.05 (two-sided). 
 
Results 
Patient characteristics: No patients were excluded and all 62 subjects entered the statistical analysis. There were no 
adverse drug reactions in any of these patients during this trial. There were no significant differences in the terms of 
gender, age, weight, primary disease, APACHE II score between the two groups (P>0.05). The mortality rates during 28 
days within both groups were 38.71% and 35.48%, the treatment group was lower than the control group, but the 
difference was not statistically significant (P>0.05). The duration of mechanical ventilation and the time of stay in ICU 
in the treatment group were less than those in the control group (P<0.05). Refer to Table 1. 
 
Table 1 Demographic characteristics 
 Control [n=31] Treatment [n=31] x
 2
/t, p value 
Gender (M/F, n) 18/13 17/14 x
2
=0.066, p=0.798 
Age（ ±s, years） 68.14±3.76 67.53±4.01 t=0.618, p=0.538 
Weight（ ±s, kg） 64.22±4.61 64.16±4.36 t=0.053, p=0.958 
APACHE II（ ±s, pions） 19.64±2.81 19.76±2.75 t=0.170, p=0.865 
Primary disease (n)   x
2
=1.368, p=0.968 
Severe pneumonia 8 7  
Pulmonary embolism 2 3  
Chest trauma 6 7  
Cerebrovascular disease 5 6  
Brain injury 6 4  
Poisoning 1 2  
Others 3 2  
Mortality rate (n, %) 12（38.71） 11（35.48） x2=0.69, p=0.793 
Duration of ventilation（ ±s, d）  13.84±3.51 11.07±3.16 t=3.266, p=0.002 
Time in ICU （ ±s, d） 16.59±2.92 13.81±2.78 t=3.839, p=0.000 
 
Change of D-lactate: At baseline, there was no statistical difference in the concentrations of D-lactate between the two 
groups (P>0.05). At 3 and 7-days following treatment, concentrations of D-lactate recorded in the treatment group were 
lower than those in control group, and these differences were statistically significant (P<0.05). Refer to Figure 1. 
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Figure 1 Comparison of D-lactate 
Note: All patients received comprehensive treatment. The patients in treatment group additionally received Kangfuxin 
Liquid, 10 ml Kangfuxin Liquid was administered by naso-gastric tube, 3 times each day, for 7 days. Treatment group 
compared with control group, 
a
P < 0.05.  
 
Change of IAP: At baseline, there was no statistical difference of the IAP between the two groups (P>0.05). At 3 and 
7-days following treatment, the IAP in treatment group was lower than those in the control group and this difference 
was statistically significant (P<0.05). Refer to figure 2. 
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Figure 2 Comparison of intra-abdominal pressure (IAP) 
Note: All patients received comprehensive treatment. The patients in treatment group additionally received Kangfuxin 
Liquid, 10 ml Kangfuxin Liquid administered by naso-gastric tube, 3 times each day, for 7 days. Treatment group 
compared with control group, 
a
P < 0.05. 
 
Change of bowel sounds: At baseline, there was no statistical difference of the bowel sounds between the two groups 
(P>0.05). At 3 and 7-days following treatment, the bowel sounds in treatment group were higher than those in control 
group, and these differences were statistically significant (P<0.05). Refer to figure 3. 
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Figure 3 Comparison of bowel sounds 
Note: All patients received comprehensive treatment. The patients in treatment group additionally received Kangfuxin 
Liquid, 10 ml Kangfuxin Liquid was administered by naso-gastric tube, 3 times each day, for 7 days. Treatment group 
compared with control group, 
a
P < 0.05. 
 
 
Discussion 
 
During the process of mechanical ventilation, the work of respiratory muscle lessens and this often leads to 
gastrointestinal dysfunction (Montejo, 1999; Mutlu et al., 2001). The physiological function in the elderly is degraded, 
the intestinal function is likewise diminished. The intestinal blood flow is reduced, intestinal blood-vessels shrink and 
intestinal mucosa is in a low state of profusion during mechanical ventilation. As intestinal mucous damage continues 
to rise, intestinal mucous barrier function starts weakening. Elderly patients in a state of mechanical ventilation are 
often fraught with panic, anxiety, depression and other adverse psychological effects. This low mood also leads to 
increased severe intestinal barrier dysfunction. Moxley (Moxley, 2000) proposed that intestinal barrier dysfunction can 
lead to intestinal bacteria and toxins being absorbed into the bloodstream and enterogenic infection can occur. This 
directly causes systemic inflammatory response syndrome (SIRS) or multiple organ dysfunction syndrome (MODS). 
Gastrointestinal tract is the portal for effective control of MODS, and effective prevention. Treatment of intestinal 
barrier dysfunction is the key to preventing the occurrence of MODS, which can reduce the mortality rate in critical 
patients (Rings, 2004). Therefore, it is important that effective intervention on intestinal barrier function in elderly 
patients having mechanical ventilation in its early stage be applied for controlling the patients' condition. 
The increased permeability of intestinal mucosa is an important manifestation of intestinal mucosal barrier 
dysfunction (Bjarnason et al., 1995). When the hypoperfusion injury of intestinal mucosa occurs, the uppermost 
epithelium along the intestinal mucosa villus shed and the permeability of intestinal mucosa increases. Surplus 
D-lactate is then produced by intestinal bacteria entering into the blood stream through the damaged mucosa and the 
level of D-lactate in plasma is increased. The level of D-lactate is positively correlated with the change of intestinal 
permeability. D-lactate is a better marker recording intestinal mucosal permeability (Sheng et al., 2015; Welch, 1999). 
The intestine is very sensitive to any increase in intra-abdominal pressure, as ischemia and hypoxia of intestinal mucosa 
often leads to intra-abdominal hypertension. Intra-abdominal hypertension can then indirectly affect the severity of 
intestinal injury (Bodnár et al., 2010). Bowel sounds is an indicator of gastrointestinal peristalsis, which can gauge the 
recovery of intestinal barrier function from pathological conditions. This marker has the advantages being simple and 
practical when assessing intestinal barrier function (Zhang et al., 2016a). 
Kangfuxin Liquid is a liquid herbal extract obtained from the dried worm of the America periplaneta. It consists of 
peptide, polyols, epidermal growth factor, sticky sugar amino acids, and other active substances. Latest research 
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indicates that Kangfuxin Liquid can reduce the level of endotoxin in patients suffering from sepsis and this enhances 
the gastrointestinal mucosal barrier function (Zhang et al., 2013). Likewise, it can aid patients suffering with 
gastrointestinal ulcers because it regulates the ph value of gastric fluid and repairs gastrointestinal mucosal tissue. 
(Zhang et al., 2012). Other studies support the case that the extract of America periplaneta can adjust the level of 
immunoglobulin A (IgA), immunoglobulin G (IgG) and other immune factors and this improves the immune function 
(Srivastava et al., 2011; Zhang et al., 2016b). In this study, the treatment group given Kangfuxin Liquid, saw D-lactate 
decreasing, intra-abdominal pressure falling and accompanying bowel sounds increasing at 3 and 7-days following 
treatment. The changes using these indicators in the “treatment” group were superior than those in the “control” group. 
These results confirm Kangfuxin Liquid as a protective medicine for intestinal mucosa promoting intestinal peristalsis 
and enhancing the intestinal barrier function. 
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